GSD NovaGen SARS CoV-2 Rapid Test is a rapid chromatographic immuniassay for the qualitative detection of SARS-CoV-2 Nucleocapsid Protein antigens present in nasopharyngeal swab specimen.
- Current mutant strains can be detected (UK, South Africa, Brazil)
- Fast results in 15 minutes
- Easy to perform, no special equipment required
- Easy collection, nasopharyngeal swabs
The GSD NovaGen SARS CoV-2 Rapid Test is manufactured and approved for use by the Therapeutic Goods Administration (TGA) .
Buy the GSD NovaGen SARS CoV-2 Rapid Test for Detecting SARS-CoV-2 for Your WorkPlace
If your company or organisation is interested in rapid testing solutions, contact us today for help procuring the GSD NovaGen SARS CoV-2 Rapid Test for Detecting SARS-CoV-2 for detecting SARS-CoV-2 or other rapid tests authorised by the Therapeutic Goods Administration (TGA) .
If you’re interested in rapid testing solutions, contact us today for a quote. You can also place an order for the GSD NovaGen SARS CoV-2 Rapid Test for Detecting SARS-CoV-2 or other rapid tests approved by the TGA.
Our team at Rapid Tests Australia can also assist with implementing a rapid testing program to protect your workplace from the risks of COVID-19.
